ASSET

Analysing and Striking the Sensitivities of Embryonal Tumours

ASSET

Using a combination of state-of-the-art genomics, proteomics and mathematical modelling, ASSET's major goal is to identify mechanistically understood network vulnerabilities that can be exploited for new approaches to the diagnosis and treatment of highly aggressive and devastating major paediatric tumours, including neuroblastoma (NB), medulloblastoma (MB) and Ewing sarcoma family tumours (ESFT).

Visit ASSET website

TOP